GlassScriptPhysician profile
Christopher P Ingelmo
NPI 1659417855
$31,320.68
in general payments reported to CMS, 2019-2025
33 companies · $1,466 in 2025
The $1,466 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,010 · 2020: $484 · 2021: $1,258 · 2022: $2,042 · 2023: $12K · 2024: $13K · 2025: $1,466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Food and Beverage: $5,144 · Travel and Lodging: $1,133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,250.00 |
| Food and Beverage | $5,144.34 |
| Travel and Lodging | $1,132.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $19,088.52 | 2021-2024 | Carto 3 |
| Biosense Webster, INC. | $5,868.51 | 2019-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Medtronic, INC. | $1,342.44 | 2021-2025 | Affera Mapping System, Cobalt Dr Mri Surescan, Micra |
| Janssen Pharmaceuticals, INC | $621.12 | 2019-2024 | Xarelto |
| Philips North America LLC | $528.49 | 2022-2024 | (Cm9) Amb Mon & Diag Und |
| Pfizer INC. | $520.15 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $515.37 | 2019-2025 | Eliquis, Camzyos |
| Medtronic Vascular, INC. | $390.74 | 2019-2020 | |
| Abbott Laboratories | $385.80 | 2021-2025 | Aveir, Cardiomems, Accent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $342.31 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $287.89 | 2022-2025 | Verquvo |
| Boston Scientific Corporation | $257.36 | 2020-2025 | Watchman Flx, Avvigo Guidance System |
| Novo Nordisk INC | $170.77 | 2024-2025 | Wegovy, Ozempic |
| Biotronik INC. | $144.01 | 2025 | Solia, Biomonitor, Pamira |
| Sanofi-Aventis U.S. LLC | $112.06 | 2019-2023 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $106.49 | 2019-2025 | Lifevest |
| Bardy Diagnostics, INC. | $90.00 | 2021-2022 | |
| Amgen INC. | $77.35 | 2019 | |
| Impulse Dynamics (USA) INC. | $71.08 | 2023 | Optimizer |
| Cardiva Medical, INC. | $67.26 | 2022-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Cordis US Corp. | $66.42 | 2025 | Mynx Control |
| Novartis Pharmaceuticals Corporation | $48.76 | 2019-2022 | |
| Convatec INC. | $33.43 | 2022 | |
| Baxter Healthcare | $32.45 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Atricure, INC. | $25.04 | 2020 | |
| Lundbeck LLC | $23.36 | 2019 | |
| Cvrx, INC. | $18.50 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $17.56 | 2023 | Inpefa |
| Lilly USA, LLC | $16.45 | 2025 | Zepbound |
| Amarin Pharma, INC. | $14.52 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $13.17 | 2024 | Wainua |
| Irhythm Technologies, INC. | $12.53 | 2019 | |
| Elutia, INC. | $10.77 | 2025 | Ecm Patch,Pouch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ingelmo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.